Discontinued — last reported Q4 '20
Constellation Brands Business Sale Proceeds increased by 22802.7% to $847.40M in Q2 2025 compared to the prior quarter.
An increase signals portfolio optimization or a strategic pivot, while a lack of proceeds suggests a stable, long-term asset base.
This metric represents the cash inflows received from the divestiture or sale of business segments, product lines, or su...
Occurs sporadically; peers often divest legacy segments to focus on high-margin innovation areas like continuous glucose monitoring or diagnostics.
proceeds_from_sale_of_business| Q1 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.00M | $0.00 | $0.00 | $96.70M | $0.00 | $6.70M | $0.00 | $0.00 | $0.00 | $409.20M | $3.70M | $847.40M |
| QoQ Change | — | -100.0% | — | — | -100.0% | — | -100.0% | — | — | — | -99.1% | >999% |
| YoY Change | — | -100.0% | — | — | — | — | -100.0% | — | — | — | — | — |